MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2021

Dec 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2021-12-03

Reporting Person: BAY CITY CAPITAL LLC (10% Owner)
Reporting Person: Bay City Capital Management IV LLC (10% Owner)
Reporting Person: Bay City Capital Fund IV, L.P. (10% Owner)
Reporting Person: BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-03	Common Stock	J	750270	$0.00	Disposed	1510521	Indirect
2021-12-03	Common Stock	J	49730	$0.00	Disposed	0	Indirect
2021-12-03	Common Stock	J	24172	$0.00	Disposed	1261	Direct

Footnotes

F1: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2: The securities are held by Fund IV.

F3: The securities were held by Co-Investment IV.

F4: Represents transfers, without the payment of any consideration, to their partners and employees.